Pregled bibliografske jedinice broj: 232697
Incidence of chromosomopathies and cystic fibrosis mutations in second trimester fetuses with isolated hyperechoic bowel
Incidence of chromosomopathies and cystic fibrosis mutations in second trimester fetuses with isolated hyperechoic bowel // The Journal of maternal-fetal medicine, 8 (1999), 2; 44-47 (podatak o recenziji nije dostupan, članak, znanstveni)
CROSBI ID: 232697 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Incidence of chromosomopathies and cystic fibrosis mutations in second trimester fetuses with isolated hyperechoic bowel
Autori
Stipoljev, Feodora ; Sertić, Jadranka ; Kos, Milan ; Miković, Borivoj ; Obrad-Sabljak, Renata ; Stavljenić Rukavina, Ana ; Latin, Višnja ; Kurjak, Asim
Izvornik
The Journal of maternal-fetal medicine (1057-0802) 8
(1999), 2;
44-47
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
fetus ; echoic bowel ; chromosomopathies ; cystic fibrosis ; prenatal diagnosis
Sažetak
Objective: Fetal echoic bowel can be a normal second trimester ultrasonographic finding which usually disappears by 20 weeks on serial sonograms. Recent studies have suggested a possible association of hyperechoic fetal bowel with chromosomopathies and cystic fibrosis. The aim of our study is to determine the incidence of chromosomopathies and cystic fibrosis mutations among the fetuses with isolated hyperechoic bowel. Methods: Sixteen fetuses with isolated echoic bowel were detected: 13 fetuses 20 weeks gestation (group I) and 3 fetuses at 20-26 weeks gestation (group II). Cytogenetic studies were performed in all 16 cases and 11 families had deoxyribonucleic acid-based risk assessment for cystic fibrosis. The echogenity of bowel was that of surrounding bone. Results: Two cases of trisomy 21 and 1 case of trisomy 13 were detected (18.7%). The other ultrasonographic markers begin to appear after 21 weeks gestation in fetuses with trisomy 13. Two of 3 pregnant women with pathological karyotype were younger than 35 years. One of 11 cases (9%) was found to be a heterozygote carrier for F508 mutation.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Renata Obrad Sabljak
(autor)
Milan Kos
(autor)
Asim Kurjak
(autor)
Feodora Stipoljev
(autor)
Jadranka Sertić
(autor)
Ana Stavljenić
(autor)
Citiraj ovu publikaciju:
Uključenost u ostale bibliografske baze podataka::
- Chemical Abstracts
- Excerpta Medica
- Index Medicus